Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD)

Inclusion Criteria: * • Male or female between 2 and 12 years of age * The subject suffers from moderate atopic dermatitis (SCORAD\<40) that is amenable to treatment * Diagnosis of atopic dermatitis meets Hanifin's criteria (at least 3 basic features and at least 3 minor features) * Atopic dermatitis is, in the opinion of the investigator, stable for the past 7 days * The subject's parents are able to apply the study product twice a day (each morning and evening) for a consecutive period of 42 days * The subject's parents agree that the subject will not change his/her lifestyle during the study period (including: regular body hygiene product (soap), the number of baths and showers per day, the laundry detergent and fabric softener used to wash clothes) * The subject's parents agree to use only the test product during the study period * The subject's legal guardian is able and willing to sign the informed consent form and to comply with the study regulations of this protocol Exclusion Criteria: * • The subject has another dermatological disease/condition that could interfere with the clinical evaluation, including infected atopic dermatitis lesions * The subject has a previous history of allergy to cosmetic products or to any of the ingredients included in the tested formulations (Appendices 1 and 2) * The subject received a topical or a systemic immune-modulator (such calcineurin inhibitors or cortico-steroids) for the treatment of atopic dermatitis, within 14 days prior to day 0 * The subject underwent phototherapy within 28 days prior to day 0 * The subject is expected to be extensively exposed to the sun during the trial * The subject underwent any experimental treatment within 14 days prior to day 0